Knott David M Jr - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
Knott David M Jr ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,054
+67.7%
185,555
+145.6%
0.78%
+60.7%
Q2 2023$1,225
-63.2%
75,549
-62.3%
0.49%
-62.7%
Q1 2023$3,333
-7.1%
200,164
-47.5%
1.31%
-3.3%
Q4 2022$3,587
-99.6%
381,621
+26.4%
1.36%
+292.8%
Q3 2022$821,000
+6.5%
301,803
+13.1%
0.34%
+6.5%
Q2 2022$771,000
+12.7%
266,803
+17.0%
0.32%
+48.6%
Q1 2022$684,000
-28.5%
228,102
+9.6%
0.22%
-32.9%
Q4 2021$957,000208,1020.32%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders